These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2678933)
1. [BCG vaccine and prevention of recurrence of superficial cancer of the bladder. Have all the possibilities been exhausted?]. Vera-Donoso CD; Llopis Minguez B; Gallego Gómez J; Jiménez Cruz JF Actas Urol Esp; 1989; 13(4):233-5. PubMed ID: 2678933 [No Abstract] [Full Text] [Related]
2. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer. Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510 [TBL] [Abstract][Full Text] [Related]
10. BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer. Debruyne FM; van der Meijden AP; Schreinemachers LM; Geboers AD; Franssen MP; van Leeuwen MJ; Steerenberg PA; de Jong WH; Ruitenberg EJ Prog Clin Biol Res; 1988; 269():511-24. PubMed ID: 3134662 [No Abstract] [Full Text] [Related]
11. BCG versus cytotoxic chemotherapy in the treatment of superficial bladder tumors. Boccon-Gibod L Prog Clin Biol Res; 1992; 378():55-7. PubMed ID: 1301586 [No Abstract] [Full Text] [Related]
12. [The prevention of recurrences of surface bladder cancer by BCG vaccinal immunotherapy]. Matveev BP; Kariakin OB; Safiullin KN; Figurin KM; Levi DT; Vatin OE Urol Nefrol (Mosk); 1993; (5):27-9. PubMed ID: 8310581 [No Abstract] [Full Text] [Related]
13. Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials. Han RF; Pan JG Urology; 2006 Jun; 67(6):1216-23. PubMed ID: 16765182 [TBL] [Abstract][Full Text] [Related]
14. [Place of endovesical "BCG Therapy" in superficial tumors of the bladder]. Zerbib M J Urol (Paris); 1995; 101(2):59-63. PubMed ID: 8522855 [TBL] [Abstract][Full Text] [Related]
15. [Long-term results and complications of intravesical instillation of bacillus Calmette-Guerin for prophylaxis of bladder cancer recurrence]. Irie A; Lee KE; Kadowaki K; Sawamura M Hinyokika Kiyo; 1994 Oct; 40(10):873-7. PubMed ID: 7992700 [TBL] [Abstract][Full Text] [Related]
16. [Intravesical instillation in the treatment of superficial tumors of the bladder]. Chopin DK Prog Urol; 1998 Apr; 8(2):268-73. PubMed ID: 9615941 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological evaluation of repeated courses of intravesical bacillus Calmette-Guerin instillation for preventing recurrence of initially resistant superficial bladder cancer. Okamura T; Tozawa K; Yamada Y; Sakagami H; Ueda K; Kohri K J Urol; 1996 Sep; 156(3):967-71. PubMed ID: 8709375 [TBL] [Abstract][Full Text] [Related]
18. [Effect of prophylactic intravesical instillation of BCG for superficial bladder cancer]. Segawa N; Inamoto T; Nomi H; Ibuki N; Azuma H; Katsuoka Y Hinyokika Kiyo; 2009 Apr; 55(4):175-80. PubMed ID: 19462820 [TBL] [Abstract][Full Text] [Related]
19. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study. Hinotsu S; Akaza H; Isaka S; Kanetake H; Kubota Y; Kuroda M; Shinohara N; Shinka T; Tachibana M; Naito S; Hirao Y; Urology; 2006 Mar; 67(3):545-9. PubMed ID: 16527576 [TBL] [Abstract][Full Text] [Related]
20. BCG in the management of superficial bladder cancer. Robinson MR Prog Clin Biol Res; 1985; 185B():161-6. PubMed ID: 3898140 [No Abstract] [Full Text] [Related] [Next] [New Search]